Literature DB >> 6295425

Prostaglandins and human lung carcinomas.

A Bennett, M A Carroll, I F Stamford, W F Whimster, F Williams.   

Abstract

Lung primary carcinomas and normal tissue from 136 patients have been extracted for prostaglandins, and the findings examined in relation to histology. In most cases, tumours yielded more prostaglandin-like material (PG-lm), as judged by bioassay, than did normal tissue from the same lungs. Amounts varied with tumour types, in the following ascending order: small-cell carcinomas, large-cell undifferentiated carcinomas, well-differentiated squamous carcinomas, poorly-differentiated adenocarcinomas, poorly differentiated squamous carcinomas, and well-differentiated adenocarcinomas. Tumour PG-lm was highest when necrosis or the neutrophil content of the tumours were moderate, whereas PG-lm from normal lung tissue correlated with the number of macrophages. Chromatography indicated the presence of various prostaglandins, in agreement with our recent findings using gas chromatography--mass spectrometry.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6295425      PMCID: PMC2011224          DOI: 10.1038/bjc.1982.298

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  10 in total

1.  PROSTAGLANDINS AND RELATED FACTORS: XIX. THIN-LAYER CHROMATOGRAPHY OF PROSTAGLANDINS.

Authors:  K GREEN; B SAMUELSSON
Journal:  J Lipid Res       Date:  1964-01       Impact factor: 5.922

2.  Improved purification and chromatography of extracts containing prostaglandins.

Authors:  I F Stamford; W G Unger
Journal:  J Physiol       Date:  1972-09       Impact factor: 5.182

3.  Change in growth and morphology of fibroblasts by prostaglandins.

Authors:  G S Johnson; I Pastan
Journal:  J Natl Cancer Inst       Date:  1971-12       Impact factor: 13.506

4.  Prostaglandins in amine-peptide-secreting tumours.

Authors:  M Sandler; S M Karim; E D Williams
Journal:  Lancet       Date:  1968-11-16       Impact factor: 79.321

5.  The mitotic index in bronchogenic carcinoma.

Authors:  W Weiss
Journal:  Am Rev Respir Dis       Date:  1971-10

6.  Prostaglandins released by the spleen.

Authors:  N Gilmore; J R Vane; J H Wyllie
Journal:  Nature       Date:  1968-06-22       Impact factor: 49.962

7.  Extraction of prostaglandins from human blood.

Authors:  W G Unger; I F Stamford; A Bennett
Journal:  Nature       Date:  1971-10-01       Impact factor: 49.962

8.  Prostaglandin E2 and gastric acid secretion in man.

Authors:  A Bennett; I F Stamford; W G Unger
Journal:  J Physiol       Date:  1973-03       Impact factor: 5.182

9.  Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells.

Authors:  P H Rolland; P M Martin; J Jacquemier; A M Rolland; M Toga
Journal:  J Natl Cancer Inst       Date:  1980-05       Impact factor: 13.506

10.  Prostaglandins and breast cancer.

Authors:  A Bennett; E M Charlier; A M McDonald; J S Simpson; I F Stamford; T Zebro
Journal:  Lancet       Date:  1977-09-24       Impact factor: 79.321

  10 in total
  5 in total

1.  NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer.

Authors:  Duncan Hughes; Taisuke Otani; Peiying Yang; Robert A Newman; Rhonda K Yantiss; Nasser K Altorki; Jeff L Port; Min Yan; Sanford D Markowitz; Madhu Mazumdar; Hsin-Hsiung Tai; Kotha Subbaramaiah; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2008-09

2.  Phase I and pharmacokinetic study of docetaxel, irinotecan, and celecoxib in patients with advanced non-small cell lung cancer.

Authors:  Athanassios Argiris; Victoria Kut; Lynn Luong; Michael J Avram
Journal:  Invest New Drugs       Date:  2006-05       Impact factor: 3.651

3.  Acetylsalicylic acid (ASA) protects the prostaglandin-cAMP-system of human hypernephroma cells against irradiation-induced alterations.

Authors:  S R Li; Q Yang; E Wandl; W Pirker; I Virgolini
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

4.  Inhibitory effects of nabumetone, a cyclooxygenase-2 inhibitor, and esculetin, a lipoxygenase inhibitor, on N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats.

Authors:  K Matsunaga; N Yoshimi; Y Yamada; M Shimizu; K Kawabata; Y Ozawa; A Hara; H Mori
Journal:  Jpn J Cancer Res       Date:  1998-05

5.  The modifying effects of indomethacin or ascorbic acid on cell proliferation induced by different types of bladder tumor promoters in rat urinary bladder and forestomach mucosal epithelium.

Authors:  M A Shibata; S Fukushima; E Asakawa; M Hirose; N Ito
Journal:  Jpn J Cancer Res       Date:  1992-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.